Hitomi Okuma Selected Research

Investigational Drugs

12/2016

Drug induced interstitial lung disease in oncology phase I trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hitomi Okuma Research Topics

Disease

2	Neoplasms (Cancer) 08/2022 - 12/2016
1	Carcinosarcoma 10/2019
1	Hemangiosarcoma (Angiosarcoma) 01/2018
1	Leiomyosarcoma 01/2018
1	Liposarcoma 01/2018
1	Neutropenia 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Disease Progression 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2016

Drug/Important Bio-Agent (IBA)

1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	Ifosfamide FDA LinkGeneric 10/2019
1	eribulin FDA Link 01/2018
1	Investigational DrugsIBA 12/2016

Therapy/Procedure

4	Therapeutics 10/2019 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018
1	Molecular Targeted Therapy 08/2022
1	Chemoradiotherapy 01/2018
1	Radiotherapy 01/2018